Methylphenidate Extended-Release 62542-0100-31
- Manufacturer
- Neos Therapeutics, Lp
- Dosage Form
- Tablet, Orally Disintegrating
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- July 1, 2026
- Listing Expires
- December 31, 2027
- Application
- NDA205489
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate | 8.6 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
62542-0100-31Selected30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62542-100-31)